Abstract:Ursodeoxycholic acid (UDCA) is a pharmaceutical ingredient widely used in clinics. As bile acid it solubilizes cholesterol gallstones and improves the liver function in case of cholestatic diseases. UDCA can be obtained from cholic acid (CA), which is the most abundant and least expensive bile acid available. The now available chemical routes for the obtainment of UDCA yield about 30% of final product. For these syntheses several protection and deprotection steps requiring toxic and dangerous reagents have to be performed, leading to the production of a series of waste products. In many cases the cholic acid itself first needs to be prepared from its taurinated and glycilated derivatives in the bile, thus adding to the complexity and multitude of steps involved of the synthetic process. For these reasons, several studies have been performed towards the development of microbial transformations or chemoenzymatic procedures for the synthesis of UDCA starting from CA or chenodeoxycholic acid (CDCA). This promising approach led several research groups to focus their attention on the development of biotransformations with non-pathogenic, easy-to-manage microorganisms, and their enzymes. In particular, the enzymatic reactions involved are selective hydrolysis, epimerization of the hydroxy functions (by oxidation and subsequent reduction) and the specific hydroxylation and dehydroxylation of suitable positions in the steroid rings. In this minireview, we critically analyze the state of the art of the production of UDCA by several chemical, chemoenzymatic and enzymatic routes reported, highlighting the bottlenecks of each production step. Particular attention is placed on the precursors availability as well as the substrate loading in the process. Potential new routes and recent developments are discussed, in particular on the employment of flow-reactors. The latter technology allows to develop processes with shorter reaction times and lower costs for the chemical and enzymatic reactions involved.

Synthesis of a Key Intermediate for Ursodeoxycholic Acid

Synthesis technology of 3-n-propyl-2, 4-dihydroxyacetophenone

Improved Synthetic Process for 3-Benzyloxy-4-n-butylaniline Hydrochloride

A new procedure for the synthesis of 2-[(4-dodecyloxyphenyl)sulfonyl]butanoic acid

Improved Synthesis of Methyl 3-Oxo-2,6,6-trimethylcyclohex-1-ene-1-carboxylate, an A-ring Intermediate for (±)Strigol

Synthesis and Chiral Resolution of 2,2- Dimethylcyclopropane Carboxylic Acid

Latest development in the synthesis of ursodeoxycholic acid (UDCA): a critical review

Synthesis of 3-Aminopyrrolidine and its N-alkylating Derivatives

Enzymatic Synthesis of New Acetoacetate–Ursodeoxycholic Acid Hybrids as Potential Therapeutic Agents and Useful Synthetic Scaffolds as Well

One-step synthesis of 12-ketoursodeoxycholic acid from dehydrocholic acid using a multienzymatic system

Study on synthesis of ursodeoxycholic acid by reduction of 7-ketolithocholic acid in double aprotic solvents and molecular simulations

Continuous Production Of Ursodeoxycholic Acid By Using Two Cascade Reactors With Co-Immobilized Enzymes

Preparation and Optimization of Amorphous Ursodeoxycholic Acid Nanosuspensions by Nanoprecipitation based on Acid-base Neutralization for Enhanced Dissolution.

Synthesis of ursodeoxycholic acid by electrochemical stereoselective reduction of 7-ketolithocholic acid in aprotic solvents

Advances in Production and Structural Derivatization of the Promising Molecule Ursolic Acid

An Improved Process for Chiron Synthesis of the Atorvastatin Side Chain

Preparation of ursodeoxycholic acid by direct electro-reduction of 7-ketolithocholic acid

Sustainable and Robust Closed-Loop Enzymatic Platform for Continuous/Semi-continuous Synthesis of Ursodeoxycholic Acid

Separation of Ursodeoxycholic Acid by Silylation Crystallization

Synthesis of a New Antihyperlipidaemic Agent-Simvastatin

Engineering 7β-Hydroxysteroid Dehydrogenase for Enhanced Ursodeoxycholic Acid Production by Multiobjective Directed Evolution.